Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cryolife Inc (CRY)  
$45.48 1.27 (2.87%) as of 4:30 Thu 12/11


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 42,700,000
Market Cap: 1.94(B)
Last Volume: 443,720 Avg Vol: 253,906
52 Week Range: $22.19 - $47.63
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Specialized Health Services

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P SMALLCAP 600

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Artivion is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Co. has the following product families: aortic stents and stent grafts, surgical sealants, On-X® mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stents and stent grafts include JOTEC® stent grafts and surgical products, the Ascyrus Medical Dissection Stent hybrid prosthesis, and the NEXUS® endovascular stent graft system. Surgical sealants include BioGlue® Surgical Adhesive products.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,100 2,100
Total Buy Value $0 $0 $53,141 $53,141
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 2 2
Total Shares Sold 265,432 389,414 631,456 996,263
Total Sell Value $12,018,007 $16,761,523 $23,072,299 $30,528,582
Total People Sold 6 6 8 12
Total Sell Transactions 23 31 52 126
End Date 2025-09-12 2025-06-11 2024-12-11 2023-12-12

   
Records found: 908
  Page 1 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Horton Amy VP, Chief Accounting Officer   •       –      –    2025-12-08 4 S $44.42 $203,084 D/D (4,572) 130,058 -0%     
   Holloway Jean F SVP, General Counsel   •       –      –    2025-12-03 4 S $45.30 $331,370 D/D (7,315) 156,093 3%     
   Mackin James P President & CEO   •       –      –    2025-12-03 4 AS $45.46 $1,405,700 D/D (30,921) 800,993 -2%     
   Mackin James P President & CEO   •       –      –    2025-12-03 4 OE $29.62 $915,880 D/D 30,921 831,914     -
   Mackin James P President & CEO   •       –      –    2025-12-02 4 AS $45.56 $1,408,730 D/D (30,921) 800,993 -2%     
   Mackin James P President & CEO   •       –      –    2025-12-02 4 OE $29.62 $915,880 D/D 30,921 831,914     -
   Horton Amy VP, Chief Accounting Officer   •       –      –    2025-12-01 4 GD $0.00 $0 D/D 750 134,630     -
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-11-21 4 S $44.91 $2,133,920 D/D (47,376) 44,753 2%     
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-11-21 4 OE $11.03 $672,988 D/D 47,376 71,828     -
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-11-20 4 S $44.14 $674,825 D/D (15,276) 44,753 -0%     
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-11-20 4 OE $11.03 $52,434 D/D 3,388 46,108     -
   Hoff Elizabeth A Director   –       •      –    2025-11-18 4 S $45.10 $189,412 D/D (4,200) 27,189 1%     
   Horton Amy VP, Chief Accounting Officer   •       –      –    2025-11-17 4 S $45.73 $274,380 D/D (6,000) 135,380 2%     
   Holloway Jean F SVP, General Counsel   •       –      –    2025-11-17 4 AS $45.17 $288,817 D/D (6,394) 163,408 -1%     
   Holloway Jean F SVP, General Counsel   •       –      –    2025-11-17 4 OE $29.62 $189,390 D/D 6,394 169,802     -
   Davis John E Chief Commercial Officer   •       –      –    2025-11-17 4 AS $45.17 $288,817 D/D (6,394) 198,842 -1%     
   Davis John E Chief Commercial Officer   •       –      –    2025-11-17 4 OE $29.62 $189,390 D/D 6,394 205,236     -
   Holloway Jean F SVP, General Counsel   •       –      –    2025-11-14 4 AS $45.00 $287,685 D/D (6,393) 163,408 -2%     
   Holloway Jean F SVP, General Counsel   •       –      –    2025-11-14 4 OE $29.62 $189,361 D/D 6,393 169,801     -
   Davis John E Chief Commercial Officer   •       –      –    2025-11-14 4 AS $44.67 $285,575 D/D (6,393) 198,842 -2%     
   Davis John E Chief Commercial Officer   •       –      –    2025-11-14 4 OE $29.62 $189,361 D/D 6,393 205,235     -
   Horton Amy VP, Chief Accounting Officer   •       –      –    2025-11-13 4 S $45.86 $159,678 D/D (3,482) 141,380 3%     
   Davis John E Chief Commercial Officer   •       –      –    2025-11-13 4 S $45.86 $300,966 D/D (6,563) 198,842 3%     
   Holloway Jean F SVP, General Counsel   •       –      –    2025-11-13 4 S $45.86 $264,188 D/D (5,761) 163,408 3%     
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2025-11-13 4 S $45.86 $228,969 D/D (4,993) 56,641 3%     
  908 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us